Skip to main content
logo
Abrdn Life Sciences Investors (HQL)
NYSE: HQL · Real-Time Price · USD
19.48
+0.07 (0.36%)
Sep 21, 2026, 11:45 AM EDT - Market open

HQL Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
592448412327343505
Market Cap Growth
-8.58%26.18%-4.83%-31.99%22.27%
Enterprise Value
586448412336352505
Last Close Price
19.4113.7111.668.558.5511.91

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PE Ratio
2.985.234.8414.62-7.83
PS Ratio
536.76231.02103.6393.42113.77220.89
PB Ratio
1.050.870.900.810.860.97
P/TBV Ratio
1.060.870.900.810.860.97
P/OCF Ratio
14.9614.12----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
EV/Sales Ratio
531.08231.02103.6396.09116.55220.89

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
----0.030.02
Net Debt / Equity Ratio
-0000.030.02
Asset Turnover
0.000.000.010.010.010.00
Quick Ratio
1.550.710.277.570.040.01
Current Ratio
1.610.730.3230.460.700.80
Return on Equity (ROE)
41.42%17.59%19.80%5.59%-22.71%12.82%
Return on Assets (ROA)
-0.61%-0.43%-0.28%-0.33%-0.39%-0.51%
Return on Capital Employed (ROCE)
-0.80%-0.70%-0.40%-0.50%-0.80%-0.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
33.27%19.11%20.68%6.84%-30.45%12.78%
Dividend Yield
9.30%13.27%14.24%14.96%17.19%14.02%
Payout Ratio
34.37%36.96%----
Buyback Yield / Dilution
-5.32%-5.48%-4.74%-4.33%-4.10%-3.29%
Total Shareholder Return
3.98%7.79%9.50%10.63%13.09%10.73%
SEC Filings: 10-K · 10-Q